Gątarek, P.; Kałużna-Czaplińska, J.; Pawełczyk, M.; Jastrzębski, K.; Giebułtowicz, J.; Głąbiński, A.; Bobrowska-Korczak, B.
LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients. Molecules 2020, 25, 4959.
https://doi.org/10.3390/molecules25214959
AMA Style
Gątarek P, Kałużna-Czaplińska J, Pawełczyk M, Jastrzębski K, Giebułtowicz J, Głąbiński A, Bobrowska-Korczak B.
LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients. Molecules. 2020; 25(21):4959.
https://doi.org/10.3390/molecules25214959
Chicago/Turabian Style
Gątarek, Paulina, Joanna Kałużna-Czaplińska, Małgorzata Pawełczyk, Karol Jastrzębski, Joanna Giebułtowicz, Andrzej Głąbiński, and Barbara Bobrowska-Korczak.
2020. "LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients" Molecules 25, no. 21: 4959.
https://doi.org/10.3390/molecules25214959
APA Style
Gątarek, P., Kałużna-Czaplińska, J., Pawełczyk, M., Jastrzębski, K., Giebułtowicz, J., Głąbiński, A., & Bobrowska-Korczak, B.
(2020). LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients. Molecules, 25(21), 4959.
https://doi.org/10.3390/molecules25214959
